Login / Signup

Efficacy and cost-efficacy of biologic therapies for moderate to severe psoriasis: a meta-analysis and cost-efficacy analysis using the intention-to-treat principle.

Ching-Chi ChiShu-Hui Wang
Published in: BioMed research international (2014)
Infliximab and ustekinumab 90 mg had the highest efficacy. Meanwhile, adalimumab had the best cost-efficacy, followed by ustekinumab 45 mg and infliximab.
Keyphrases
  • rheumatoid arthritis
  • ulcerative colitis
  • systemic lupus erythematosus
  • high intensity